Peanut-allergic patients in the MIRABEL survey: characteristics, allergists' dietary advice and lessons from real life

[en] Background The MIRABEL survey is an observational study on peanut allergy in France, Belgium and Luxemburg. The objectives are to provide data on a large population, to analyse the consumer behaviour, to study the presence of peanut traces in pre-packed foods with/without precautionary allergen labelling (PAL), and to combine these data to quantify allergic risk and produce a cost/benefit analysis. This paper reports a real-life observatory of 785 patients (< 16y: 86%): medical characteristics, eliciting doses (ED) in real life and in oral food challenges (OFC), factors associated with severe reactions, allergist dietary advice and patients’ anxiety regarding their allergy. Methods Age and symptoms at diagnosis, route of exposure, comorbidities, allergy tests, ED (OFC/real life; mg peanut protein), dietary advice about PAL, and anxiety score were recorded. Results Median age was 3 years; 85% were declared allergic. Severe/potentially severe reactions were reported in 30% of the allergic patients: serious systemic reaction (15%), laryngeal angioedema (8%), shock (4%) and acute asthma (3%); 66% had atopic dermatitis, 58% asthma. Median ara h 2 sIgE level was 11.5 kUA/L. Of the 278 OFCs, 225 were positive (median ED: 67.3 mg). Real-life ED was < 100 mg in 44.3%. Severe reactions were significantly more frequent in teenagers and adults (P = 0.004), asthmatic patients (P = 0.033), and patients who reacted to inhalation (P < 0.001). No significant association was found for OFC ED or ara h 2 sIgE. Factors associated with strict avoidance advice including PAL were OFC ED < 100 mg (P < 0.001), but not severe reaction history (P = 0.051) or asthma (P = 0.34). Anxiety was significantly associated with strict avoidance (P < 0.001). Conclusion and clinical relevance Severe/potentially severe reactions, allergic comorbidities, and low EDs in real life are frequent in peanut-allergic patients. Asthma, teenage/ adulthood and reaction to inhalation are associated with severe symptoms. PAL and criteria guiding dietary advice need to be improved.

Disciplines :

Endocrinology, metabolism & nutrition
Human health sciences: Multidisciplinary, general & others

Author, co-author :

Deschildre, A

Elegbédé, CF

Just, J

Bruyère, Olivier ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Van der Brempt, X

Papadopoulos, A

Beaudouin, E

Renaudin, JM

Crepet, A

Moneret-Vautrin, DA

Language :

English

Title :

Peanut-allergic patients in the MIRABEL survey: characteristics, allergists' dietary advice and lessons from real life

Publication date :

April 2016

Journal title :

Clinical and Experimental Allergy

ISSN :

0954-7894

eISSN :

1365-2222

Publisher :

Blackwell Publishing, Oxford, United Kingdom

Volume :

Issue :

Pages :

610-20

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 07 September 2016

Statistics

Number of views

114 (1 by ULiège)

Number of downloads

1 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Nwaru BI, Hickstein L, Panesar SS, Roberts G, Muraro A, Sheikh A, EAACI Food Allergy and Anaphylaxis Guidelines Group. Prevalence of common FA in Europe: a systematic review and meta-analysis. Allergy 2014; 69:992-1007.
Morisset M, Moneret-Vautrin DA, Kanny G, Allergo-Vigilance Network. Prevalence of peanut sensitization in a population of 4737 subjects-an Allergo-Vigilance Network enquiry carried out in 2002. Eur Ann Allergy Clin Immunol 2005; 37:54-7.
Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 2007; 119:1018-9.
Summers CW, Pumphrey RS, Woods CN, McDowell G, Pemberton PW, Arkwright PD. Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center. J Allergy Clin Immunol 2008; 121:632-8.
Turner PJ, Skypala IJ, Fox AT. Advice provided by health professionals regarding precautionary allergen labelling. Pediatr Allergy Immunol 2014; 25:290-2.
Allen KJ, Turner PJ, Pawankar R et al. Precautionary labelling of foods for allergen content: are we ready for a global framework? World Allergy Organ J 2014; 7:10.
Crépet A, Papadopoulos A, Elégbédé CF et al. MIRABEL: an integrated framework for risk and cost/benefit analysis of peanut allergen. Regul Toxicol Pharmcol 2015; 71:178-83.
Flokstra-de Blok BM, DunnGalvin A, Vlieg-Boerstra BJ et al. Development and validation of the self-administered Food Allergy Quality of Life Questionnaire for adolescents. J Allergy Clin Immunol 2008; 122:139-44.
Flokstra-de Blok BM, DunnGalvin A, Vlieg-Boerstra BJ et al. Development and validation of a self-administered Food Allergy Quality of Life Questionnaire for children. Clin Exp Allergy 2009; 39:127-37.
Flokstra-de Blok BM, van der Meulen GN, DunnGalvin A et al. Development and validation of the Food Allergy Quality of Life Questionnaire - Adult Form. Allergy 2009; 64:1209-17.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-83.
ANSES 2013: Table de composition nutritionnelle des aliments Ciqual. Available at https://pro.anses.fr/TableCIQUAL/
Sampson H. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001; 107:891-6.
Roberts G, Lack G. Diagnosing peanut allergy with skin prick and specific IgE testing. J Allergy Clin Immunol 2005; 115:1291-6.
Codreanu F, Collignon O, Roitel O et al. A novel immunoassay using recombinant allergens simplifies peanut allergy diagnosis. Int Arch Allergy Immunol 2011; 154:216-26.
Nicolaou N, Murray C, Belgrave D, Poorafshar M, Simpson A, Custovic A. Quantification of specific IgE to whole peanut extract and peanut components in prediction of peanut allergy. J Allergy Clin Immunol 2011; 127:684-5.
Santos C, Deschildre A, Paty E, Couderc L, Marguet C, Rancé F. Test de provocation par voie orale aux aliments chez l'enfant. Quand, pour qui et comment ? Réalisation. Rev Fr Allergol Immunol Clin 2006; 46:659-69.
Vereda A, van Hage M, Ahlstedt S et al. Peanut allergy: clinical and immunologic differences among patients from 3 different geographic regions. J Allergy Clin Immunol 2011; 127:603-7.
Johannsen H, Nolan R, Pascoe EM et al. Skin prick testing and peanut-specific IgE can predict peanut challenge outcomes in preschoolchildren with peanut sensitization. Clin Exp Allergy 2011; 41:994-1000.
Peters RL, Allen KJ, Dharmage SC et al. HealthNuts study. Natural history of peanut allergy and predictors of resolution in the first 4 years of life: a population-based assessment. J Allergy Clin Immunol 2015; 135:1257-66.
Deschildre A, Marguet C, Salleron J et al. Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey. Eur Respir J 2013; 42:1224-33.
Just J, Saint-Pierre P, Gouvis-Echraghi R et al. Childhood allergic asthma is not a single phenotype. J Pediatr 2014; 164:815-20.
Roberts G, Patel N, Levi-Schaffer F, Habibi P, Lack G. Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled study. J Allergy Clin Immunol 2003; 112:168-74.
Marenholz I, Kerscher T, Bauerfeind A et al. An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma. J Allergy Clin Immunol 2009; 123:911-6.
van der Zee T, Dubois A, Kerkhof M, van der Heide S, Vlieg-Boerstra B. The eliciting dose of peanut in double-blind, placebo-controlled food challenges decreases with increasing age and specific IgE level in children and young adults. J Allergy Clin Immunol 2011; 128:1031-6.
Vetander M, Helander D, Flodström C et al. Anaphylaxis and reactions to foods in children-a population-based case study of emergency department visits. Clin Exp Allergy 2012; 42:568-77.
Comstock SS, DeMera R, Vega LC et al. Allergic reactions to peanuts, tree nuts, and seeds aboard commercial airliners. Ann Allergy Asthma Immunol 2008; 101:51-6.
Keet CA, Johnson K, Savage JH, Hamilton RG, Wood RA. Evaluation of Ara h2 IgE thresholds in the diagnosis of peanut allergy in a clinical population. J Allergy Clin Immunol Pract 2013; 1:101-3.
Astier C, Morisset M, Roitel O et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol 2006; 118:250-6.
Eller E, Bindslev-Jensen C. Clinical value of component-resolved diagnostics in peanut-allergic patients. Allergy 2013; 68:190-4.
Blumchen K, Beder A, Beschorner J et al. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy. J Allergy Clin Immunol 2014; 134:390-8.
Taylor SL, Moneret-Vautrin DA, Crevel RW et al. Threshold dose for peanut: risk characterization based upon diagnostic oral challenge of a series of 286 peanut-allergic individuals. Food Chem Toxicol 2010; 48:814-9.
Hourihane JO, Grimshaw KE, Lewis SA et al. Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community? Clin Exp Allergy 2005; 35:1227-33.
Wassenberg J, Cochard MM, Dunngalvin A et al. Parent perceived quality of life is age-dependent in children with food allergy. Pediatr Allergy Immunol 2012; 23:412-9.
Saleh-Langenberg J, Goossens NJ, Flokstra-de Blok BM et al. Predictors of health-related quality of life of European food-allergic patients. Allergy 2015; 70:616-24.
Brough HA, Turner PJ, Wright T et al. Dietary management of peanut and tree nut allergy: what exactly should patients avoid? Clin Exp Allergy 2015; 45:859-71.
Taylor SL, Baumert JL, Kruizinga AG, Houben G. Establishment of reference doses for residues of allergenic foods: report of the VITAL expert panel. Food Chem Toxicol 2014; 63:9-17.
Allen KJ, Remington BC, Baumert JL et al. Allergen reference doses for precautionary labeling (VITAL 2.0): clinical implications. J Allergy Clin Immunol 2014; 133:156-64.
DunnGalvin A, Chan CH, Crevel R et al. Precautionary allergen labelling: perspectives from key stakeholder groups. Allergy 2015; 70:1039-51.